Kiora Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $2.48 | $2.48 | $2.48 |
| Q2 2024 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q3 2024 | 2 | -$0.76 | -$0.76 | -$0.76 |
| Q4 2024 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q1 2025 | 1 | -$0.71 | -$0.71 | -$0.71 |
| Q2 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2025 | 1 | -$0.53 | -$0.53 | -$0.53 |
| Q4 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
Kiora Pharmaceuticals, Inc. Earnings Date And Information
Kiora Pharmaceuticals, Inc. last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.53 earnings per share for the quarter, topping analysts' consensus estimates of $-0.95 by $0.42. The company had revenue of 20,000 for the quarter and had revenue of 0 for the year. Kiora Pharmaceuticals, Inc. has generated $-24 earnings per share over the last year ($-23.26 diluted earnings per share) and currently has a price-to-earnings ratio of 4.59. Kiora Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Kiora Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2024 | Q2 2024 | -$0.95 | -$0.53 | 0.42 | $20,000 | $20,000 |
| 05/10/2024 | Q1 2024 | $5.58 | $0.52 | -5.06 | $16.00 M | |
| 03/25/2024 | Q4 2023 | -$0.42 | -$0.29 | 0.13 | $283,872 | |
| 11/09/2023 | Q3 2023 | -$2.70 | -$0.81 | 1.89 | $0 | |
| 08/08/2023 | Q2 2023 | -$4.59 | -$0.79 | 3.8 | $0 | |
| 05/09/2023 | Q1 2023 | -$1.68 | -$1.20 | 0.48 | $0 | |
| 03/23/2023 | Q4 2022 | -$2.46 | -$1.52 | 0.94 | $0 | |
| 11/09/2022 | Q3 2022 | -$3.83 | -$7.70 | -3.87 | $0 | |
| 08/12/2022 | Q2 2022 | -$72.01 | -$7.35 | 64.66 | $0 | |
| 07/08/2022 | Q1 2022 | -$11.25 | $0 | |||
| 04/15/2022 | Q4 2021 | -$32.65 | $0 | |||
| 11/15/2021 | Q3 2021 | -$122.41 | -$11.56 | 110.85 | $0 | |
| 08/12/2021 | Q2 2021 | -$16.67 | -$13.23 | 3.44 | $0 | |
| 05/12/2021 | Q1 2021 | -$15.40 | -$14.03 | 1.37 | $0 | |
| 03/25/2021 | Q4 2020 | -$17.60 | -$21.25 | -3.65 | $12,059 | |
| 11/09/2020 | Q3 2020 | -$16.80 | -$17.65 | -0.85 | $0 | |
| 08/06/2020 | Q2 2020 | -$17.20 | -$15.13 | 2.07 | $0 | |
| 05/06/2020 | Q1 2020 | -$17.26 | $0 | |||
| 03/04/2020 | Q4 2019 | -$32.40 | -$36.23 | -3.83 | $0 | |
| 11/07/2019 | Q3 2019 | -$45.97 | $0 |
Kiora Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Kiora Pharmaceuticals, Inc.'s earnings date?
Kiora Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Kiora Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Kiora Pharmaceuticals, Inc. (:KPRX) reported $-0.53 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.95 by $0.42.
-
How can I listen to Kiora Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Kiora Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Kiora Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Kiora Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Kiora Pharmaceuticals, Inc. generate each year?
Kiora Pharmaceuticals, Inc. (:KPRX) has a recorded net income of $0. Kiora Pharmaceuticals, Inc. has generated $-24.25 earnings per share over the last four quarters.
-
What is Kiora Pharmaceuticals, Inc.'s price-to-earnings ratio?
Kiora Pharmaceuticals, Inc. (:KPRX) has a price-to-earnings ratio of 4.59 and price/earnings-to-growth ratio is 0.24.
